The findings from the present study indicate that a patient’s serum IL-8 level may reflect his or her tumor microenvironment, which shows the expression of IL-8 in cancer cells and the infiltration of CD163-positive macrophages into the tumor invasive front. The gene discussed is CD163; the disease is neoplasm.